September 9, 2024-September 11, 2024 Register Now for C-Path’s Premier Global Impact Conference We are thrilled to invite you to the inaugural Critical Path Institute Global Impact Conference taking place this September...
Advances in Tuberculosis Diagnostics: The Xpert MTB/RIF Assay and Future Prospects for a Point-of-Care Test
FDA Works with Partners to Establish Important Therapeutic Area Data Standards Clarification, November 5, 2012: CFAST is a joint initiative of CDISC and the Critical Path Institute. The FDA and TransCelerate B
